Emmett Schmidt

Company: Merck

Job title: Vice President

Seminars:

The Independent Action Model for Cancer Drug Combination Activity: Why Preclinical Combination Models are Failing at an Unprecedented Rate in the Clinic 9:45 am

• Highlighting the need for clear rationales to develop combination therapies • Exploring the importance of defining synergy to reduce the failure rates of current clinical trialsRead more

day: Day One